Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001308411-13-000092
Filing Date
2013-04-25
Accepted
2013-04-25 10:26:46
Documents
11
Period of Report
2011-07-31

Document Format Files

Seq Description Document Type Size
1 TAMIR BIOTECHNOLOGY, INC. FORM 10-K JULY 31, 2011 form10k110731.htm 10-K 778903
2 EXHIBIT 21.1 exhibit21_1.htm EX-21.1 605
3 EXHIBIT 31.1 exhibit31_1.htm EX-31.1 7104
4 EXHIBIT 31.2 exhibit31_2.htm EX-31.2 5799
5 EXHIBIT 32.1 exhibit32_1.htm EX-32.1 4019
  Complete submission text file 0001308411-13-000092.txt   2220622

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE acel-20110731.xml EX-101.INS 201003
7 XBRL SCHEMA FILE acel-20110731.xsd EX-101.SCH 10310
8 XBRL CALCULATION FILE acel-20110731_cal.xml EX-101.CAL 34602
9 XBRL DEFINITION FILE acel-20110731_def.xml EX-101.DEF 15563
10 XBRL LABEL FILE acel-20110731_lab.xml EX-101.LAB 110577
11 XBRL PRESENTATION FILE acel-20110731_pre.xml EX-101.PRE 73493
Mailing Address 300 ATRIUM DRIVE SOMERSET NJ 08873
Business Address 300 ATRIUM DRIVE SOMERSET NJ 08873 732-652-4525
Tamir Biotechnology, Inc. (Filer) CIK: 0000708717 (see all company filings)

EIN.: 222369085 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-11088 | Film No.: 13781364
SIC: 2836 Biological Products, (No Diagnostic Substances)